Analysis of gene expression for studying tumor progression: The case of glucocorticoid administration

Gene

Volumn 549, Issue 1, 2014, Pages 33-40

  Huerta, Mario ^a   Fernández Márquez, José ^a   Cabello, Jose Luis ^a   Medrano, Alberto ^a   Querol, Enric ^a   Cedano, Juan ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

Cancer; Cell stress; Gene expression; Glucocorticoid; NEDD4L

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

ARTICLE; CELL PROLIFERATION; CELL STRESS; GENE EXPRESSION; GENOMICS; HUMAN; MICROARRAY ANALYSIS; NEOPLASM; PHENOTYPE; PRIORITY JOURNAL; TUMOR GROWTH;

CANCER; CELL STRESS; GENE EXPRESSION; GLUCOCORTICOID; NEDD4L;

CELL LINE, TUMOR; CLUSTER ANALYSIS; DEXAMETHASONE; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; GLUCOCORTICOIDS; HUMANS; LINEAR MODELS; NEOPLASMS; PHENOTYPE; TISSUE ARRAY ANALYSIS;

EID: 84905719549     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.07.027     Document Type: Article

References (46)

1. Ahren K., Jacobsohn D. The action of cortisone on the mammary glands of rats under various states of hormonal imbalance. Acta Physiol. Scand. 2008, 40(2-3):254-274.
2. Araki N., Ishigami T., Ushio H., Minegishi S., Umemura M., Miyagi Y., Aoki I., Morinaga H., Tamura K., Toya Y., et al. Identification of NPC2 protein as interaction molecule with C2 domain of human NEDD4L. Biochem. Biophys. Res. Commun. 2009, 388(2):290-296.
3. Billing A.M., Fack F., Renaut J., Olinger C.M., Schote A.B., Turner J.D., Muller C.P. Proteomic analysis of the cortisol-mediated stress response in THP-1 monocytes using DIGE technology. J. Mass Spectrom. 2007, 42(11):1433-1444.
4. Binder E.B. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 2009, 34(Suppl. 1):S186-S195.
5. Cedano J., Huerta M., Estrada I., Ballllosera F., Conchillo O., Delicado P., Querol E. A web server for automatic analysis and extraction of relevant biological knowledge. Comput. Biol. Med. 2007, 37(11):1672-1675.
6. Cedano J., Huerta M., Querol E. NCR-PCOPGene: an exploratory tool for analysis of sample-classes effect on gene-expression relationships. Adv. Bioinforma. 2008, 789026.
7. Chen Y.X., Li Z.B., Diao F., Cao D.M., Fu C.C., Lu J. Up-regulation of RhoB by glucocorticoids and its effects on the cell proliferation and NF-kappaB transcriptional activity. J. Steroid Biochem. Mol. Biol. 2006, 101(4-5):179-187.
8. Clarke R.M. The time-course of changes in mucosal architecture and epithelial cell production and cell shedding in the small intestine of the rat fed after fasting. J. Anat. 1975, 120(Pt 2):321-327.
9. Delicado P., Huerta M. Principal curves of oriented points: theoretical and computational improvements. Comput. Stat. 2003, 18(2):293-315.
10. Furukawa T., Sunamura M., Motoi F., Matsuno S., Horii A. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am. J. Pathol. 2003, 162(6):1807-1815.
11. Gargett C.E., Chan R.W., Schwab K.E. Hormone and growth factor signaling in endometrial renewal: role of stem/progenitor cells. Mol. Cell. Endocrinol. 2008, 288(1-2):22-29.
12. Gozgit J.M., Pentecost B.T., Marconi S.A., Otis C.N., Wu C., Arcaro K.F. Use of an aggressive MCF-7 cell line variant, TMX2-28, to study cell invasion in breast cancer. Mol. Cancer Res. 2006, 4(12):905-913.
13. Heine V.M., Priller M., Ling J., Rowitch D.H., Schuller U. Dexamethasone destabilizes Nmyc to inhibit the growth of hedgehog-associated medulloblastoma. Cancer Res. 2010, 70(13):5220-5225.
14. Herr I., Pfitzenmaier J. Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases. Lancet Oncol. 2006, 7(5):425-430.
15. Herr I., Ucur E., Herzer K., Okouoyo S., Ridder R., Krammer P.H., von Knebel Doeberitz M., Debatin K.M. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Cancer Res. 2003, 63(12):3112-3120.
16. Huerta M., Cedano J., Querol E. Analysis of nonlinear relations between expression profiles by the principal curves of oriented-points approach. J. Bioinforma. Comput. Biol. 2008, 6(2):367-386.
17. Huerta M., Cedano J., Pena D., Rodriguez A., Querol E. PCOPGene-Net: holistic characterisation of cellular states from microarray data based on continuous and non-continuous analysis of gene-expression relationships. BMC Bioinforma. 2009, 10:138.
18. Jasonni V.M., La Marca A., Santini D. Progestin effects on epidermal growth factor receptor (EGFR) endometrial expression in normal and hyperplastic endometrium. Int. J. Gynaecol. Obstet. 2005, 89(3):297-298.
19. Kaup B., Schindler I., Knupfer H., Schlenzka A., Preiss R., Knupfer M.M. Time-dependent inhibition of glioblastoma cell proliferation by dexamethasone. J. Neurooncol. 2001, 51(2):105-110.
20. Kohonen T., Somervuo P. How to make large self-organizing maps for nonvectorial data. Neural Netw. 2002, 15(8-9):945-952.
21. Kumar V., Abbas A.K., Fausto N., Aster J. Robbins and Cotran Pathologic Basis of Disease, Professional Edition: Expert Consult 2009, 74-1009. Saunders Elsevier, (9th(3)).
22. Lu Y.S., Lien H.C., Yeh P.Y., Kuo S.H., Chang W.C., Kuo M.L., Cheng A.L. Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity. Lung Cancer 2006, 53(3):303-310.
23. Mattern J., Buchler M.W., Herr I. Cell cycle arrest by glucocorticoids may protect normal tissue and solid tumors from cancer therapy. Cancer Biol. Ther. 2007, 6(9):1345-1354.
24. Meijer E., Sonneveld P. Hematology: lenalidomide plus dexamethasone is effective in multiple myeloma. Nat. Rev. Clin. Oncol. 2009, 6(5):247-248.
25. Mukaide H., Adachi Y., Taketani S., Iwasaki M., Koike-Kiriyama N., Shigematsu A., Shi M., Yanai S., Yoshioka K., Kamiyama Y., et al. FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma. Cancer Invest. 2008, 26(4):385-390.
26. Newmark H.L., Lipkin M., Maheshwari N. Colonic hyperproliferation induced in rats and mice by nutritional-stress diets containing four components of a human Western-style diet (series 2). Am. J. Clin. Nutr. 1991, 54(1 Suppl.):209S-214S.
27. Okudela K., Yazawa T., Woo T., Sakaeda M., Ishii J., Mitsui H., Shimoyamada H., Sato H., Tajiri M., Ogawa N., et al. Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis. Am. J. Pathol. 2009, 175(2):867-881.
28. Persaud A., Alberts P., Amsen E.M., Xiong X., Wasmuth J., Saadon Z., Fladd C., Parkinson J., Rotin D. Comparison of substrate specificity of the ubiquitin ligases NEDD4 and NEDD4-2 using proteome arrays. Mol. Syst. Biol. 2009, 5:333.
29. Phesse T.J., Clarke A.R. Normal stem cells in cancer prone epithelial tissues. Br. J. Cancer 2009, 100(2):221-227.
30. Phillips R.S., Gopaul S., Gibson F., Houghton E., Craig J.V., Light K., Pizer B. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood. Cochrane Database Syst. Rev. 2010, 9:CD007786.
31. Poole A.J., Li Y., Kim Y., Lin S.C., Lee W.H., Lee E.Y. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist. Science 2006, 314(5804):1467-1470.
32. Powe D. Beta-blockers help reduce metastasis and improve survival in patients. 7th European Breast Cancer Conference 2010, EBCC7.
33. Reiche E.M., Morimoto H.K., Nunes S.M. Stress and depression-induced immune dysfunction: implications for the development and progression of cancer. Int. Rev. Psychiatry 2005, 17(6):515-527.
34. Scherf U., Ross D.T., Waltham M., Smith L.H., Lee J.K., Tanabe L., Kohn K.W., Reinhold W.C., Myers T.G., Andrews D.T., et al. A gene expression database for the molecular pharmacology of cancer. Nat. Genet. 2000, 24(3):236-244.
35. Sherlock P., Hartmann W.H. Adrenal steroids and the pattern of metastases of breast cancer. JAMA 1962, 181:313-317.
36. Singh P., Velasco M., Given R., Wargovich M., Varro A., Wang T.C. Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 278(3):G390-G399.
37. Sloan E.K., Priceman S.J., Cox B.F., Yu S., Pimentel M.A., Tangkanangnukul V., Arevalo J.M., Morizono K., Karanikolas B.D., Wu L., et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010, 70(18):7042-7052.
38. Snyder P.M., Olson D.R., Kabra R., Zhou R., Steines J.C. cAMP and serum and glucocorticoid-inducible kinase (SGK) regulate the epithelial Na(+) channel through convergent phosphorylation of NEDD4-2. J. Biol. Chem. 2004, 279(44):45753-45758.
39. Sui M., Chen F., Chen Z., Fan W. Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors. Int. J. Cancer 2006, 119(3):712-717.
40. Theocharis S., Kouraklis G., Margeli A., Agapitos E., Ninos S., Karatzas G., Koutselinis A. Glucocorticoid receptor (GR) immunohistochemical expression is correlated with cell cycle-related molecules in human colon cancer. Dig. Dis. Sci. 2003, 48(9):1745-1750.
41. Tien E.S., Davis J.W., Vanden Heuvel J.P. Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator. J. Biol. Chem. 2004, 279(23):24053-24063.
42. Tutton P.J., Barkla D.H. Effects of glucocorticoid hormones on cell proliferation in dimethylhydrazine-induced tumours in rat colon. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 1981, 38(2):247-251.
43. Watanabe K., Tachibana O., Sata K., Yonekawa Y., Kleihues P., Ohgaki H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol. 1996, 6(3):217-223. (discussion 223-214).
44. Wu C.J., Kasif S. GEMS: a web server for biclustering analysis of expression data. Nucleic Acids Res. 2005, 33(Web Server issue):W596-599.
45. Yamamoto T., Nishiguchi M., Inoue N., Goto H.G., Kudawara I., Ueda T., Yoshikawa H., Tanigaki Y., Nishizawa Y. Inhibition of murine osteosarcoma cell proliferation by glucocorticoid. Anticancer Res. 2002, 22(6C):4151-4156.
46. Zhang C., Kolb A., Buchler P., Cato A.C., Mattern J., Rittgen W., Edler L., Debatin K.M., Buchler M.W., Friess H., et al. Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer. BMC Cancer 2006, 6:61.